{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:26:01Z","timestamp":1789118761780,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001794","name":"The University of Queensland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Management of recurrent vulvovaginal candidiasis remains challenging. It is treated by healthcare professionals across disciplines including general practice, pharmacy, and complementary medicine. Conventional antifungal regimens supported by formal treatment guidelines are the standard of care. No standardised guidance exists for complementary medicine, and the treatments used in contemporary practice remain largely undocumented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To identify treatments recommended for recurrent vulvovaginal candidiasis across healthcare disciplines and the sources used to inform clinical decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      A national cross-sectional, open, anonymous, self-administered online survey of Australian healthcare professionals from conventional and complementary medicine disciplines was conducted between November 2022 and September 2023 using a 19-item questionnaire. The questionnaire captured treatment recommendations for recurrent or persistent\n                      <jats:italic>Candida<\/jats:italic>\n                      -related vulvovaginal symptoms, including conventional and complementary medicines, over-the-counter products, and lifestyle strategies such as dietary and hygiene advice, and information sources used in diagnosis and management.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 223 healthcare professionals from 13 disciplines met the inclusion criteria, comprising 68 conventional medicine and 155 complementary medicine practitioners. Overall, 122 different treatments were identified, including 69 distinct herbal medicines, reflecting substantial variation in clinical recommendations across disciplines. Conventional medicines were recommended by 43.9% of respondents, herbal medicines by 65.0%, and nutrient-based interventions by 86.1%. Oral fluconazole and intravaginal clotrimazole were the most frequently recommended conventional agents. Probiotics, administered either orally or intravaginally, were cited across professional groups. Frequently recommended herbal medicines included\n                      <jats:italic>Allium sativum<\/jats:italic>\n                      (garlic),\n                      <jats:italic>Handroanthus impetiginosus<\/jats:italic>\n                      (pau d\u2019arco), and\n                      <jats:italic>Pseudowintera colorata<\/jats:italic>\n                      (horopito). Common lifestyle strategies included reducing dietary sugar, alcohol moderation, avoiding synthetic underwear, and modifying post-toileting hygiene practices. Information sources also differed by discipline, with conventional medicine practitioners more often consulting the Therapeutic Guidelines (eTG) and complementary medicine practitioners more commonly consulting peer-reviewed journal articles.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Practitioner-reported recurrent vulvovaginal candidiasis management included a broad range of treatment strategies across healthcare disciplines. The heterogeneity of recommendations, together with overlap across disciplines, supports further evaluation of selected treatments and evidence-informed cross-disciplinary guidance to support safer, more coordinated care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02165-5","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:23:23Z","timestamp":1779798203000},"page":"1926-1936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment recommendations for recurrent vulvovaginal candidiasis across complementary and conventional disciplines: a national survey of Australian healthcare professionals"],"prefix":"10.1007","volume":"48","author":[{"given":"Rommy","family":"Everingham-Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Steels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy J.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Steadman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"11","key":"2165_CR1","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","volume":"18","author":"DW Denning","year":"2018","unstructured":"Denning DW, Kneale M, Sobel JD, et al. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339\u201347. https:\/\/doi.org\/10.1016\/S1473-3099(18)30103-8.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"2165_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01521-24","volume":"12","author":"Y Liang","year":"2024","unstructured":"Liang Y, Huang Z, Fan S, et al. Highlight signatures of vaginal microbiota and metabolome contributed to the occurrence and recurrence of vulvovaginal candidiasis. Microbiol Spectr. 2024;12(12):e0152124. https:\/\/doi.org\/10.1128\/spectrum.01521-24.","journal-title":"Microbiol Spectr"},{"issue":"5","key":"2165_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2019.10.008","volume":"222","author":"BA Tortelli","year":"2020","unstructured":"Tortelli BA, Lewis WG, Allsworth JE, et al. Associations between the vaginal microbiome and Candida colonization in women of reproductive age. Am J Obstet Gynecol. 2020;222(5):e1\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2019.10.008.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2165_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-024-03217-6","volume":"24","author":"AK Sarpong","year":"2024","unstructured":"Sarpong AK, Odoi H, Boakye YD, et al. Resistant C. albicans implicated in recurrent vulvovaginal candidiasis (RVVC) among women in a tertiary healthcare facility in Kumasi, Ghana. BMC Womens Health. 2024;24(1):412. https:\/\/doi.org\/10.1186\/s12905-024-03217-6.","journal-title":"BMC Womens Health"},{"issue":"9","key":"2165_CR5","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1128\/JCM.00218-06","volume":"44","author":"MV Pirotta","year":"2006","unstructured":"Pirotta MV, Garland SM. Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics. J Clin Microbiol. 2006;44(9):3213\u20137. https:\/\/doi.org\/10.1128\/JCM.00218-06.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2165_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/birt.12526","volume":"48","author":"P Foessleitner","year":"2021","unstructured":"Foessleitner P, Petricevic L, Boerger I, et al. HIV infection as a risk factor for vaginal dysbiosis, bacterial vaginosis, and candidosis in pregnancy: a matched case-control study. Birth. 2021;48(1):139\u201346. https:\/\/doi.org\/10.1111\/birt.12526.","journal-title":"Birth"},{"issue":"1","key":"2165_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-95772-7","volume":"15","author":"GS Omosa-Manyonyi","year":"2025","unstructured":"Omosa-Manyonyi GS, Ponce IR, Rosati D, et al. Genetic susceptibility to recurrent vulvovaginal candidiasis in an African population from Nairobi, Kenya. Sci Rep. 2025;15(1):12149. https:\/\/doi.org\/10.1038\/s41598-025-95772-7.","journal-title":"Sci Rep"},{"key":"2165_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.934353","volume":"12","author":"G Donders","year":"2022","unstructured":"Donders G, Sziller IO, Paavonen J, et al. Management of recurrent vulvovaginal candidosis: narrative review of the literature and European expert panel opinion. Front Cell Infect Microbiol. 2022;12:934353. https:\/\/doi.org\/10.3389\/fcimb.2022.934353.","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"2165_CR9","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1093\/infdis\/jiaa444","volume":"225","author":"D Rosati","year":"2022","unstructured":"Rosati D, Bruno M, Jaeger M, et al. An exaggerated monocyte-derived cytokine response to Candida hyphae in patients with recurrent vulvovaginal candidiasis. J Infect Dis. 2022;225(10):1796\u2013806. https:\/\/doi.org\/10.1093\/infdis\/jiaa444.","journal-title":"J Infect Dis"},{"key":"2165_CR10","volume-title":"WHO fungal priority pathogens list to guide research, development and public health action","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization; 2022."},{"key":"2165_CR11","doi-asserted-by":"publisher","DOI":"10.2471\/B09108","volume-title":"Recommendations for the treatment of Trichomonas vaginalis, Mycoplasma genitalium, Candida albicans, bacterial vaginosis and human papillomavirus (anogenital warts)","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Recommendations for the treatment of Trichomonas vaginalis, Mycoplasma genitalium, Candida albicans, bacterial vaginosis and human papillomavirus (anogenital warts). Geneva: World Health Organization; 2024."},{"issue":"4","key":"2165_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/LGT.0000000000000413","volume":"22","author":"T Crouss","year":"2018","unstructured":"Crouss T, Sobel JD, Smith K, et al. Long-term outcomes of women with recurrent vulvovaginal candidiasis after a course of maintenance antifungal therapy. J Low Genit Tract Dis. 2018;22(4):382\u20136. https:\/\/doi.org\/10.1097\/LGT.0000000000000413.","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"2165_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-01973-x","volume":"22","author":"M Bradfield Strydom","year":"2022","unstructured":"Bradfield Strydom M, Walpola RL, McMillan S, et al. Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey. BMC Womens Health. 2022;22(1):384. https:\/\/doi.org\/10.1186\/s12905-022-01973-x.","journal-title":"BMC Womens Health"},{"issue":"4","key":"2165_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/713683045","volume":"18","author":"A Chapple","year":"2000","unstructured":"Chapple A, Hassell K, Nicolson M, et al. \u201cYou don\u2019t really feel you can function normally\u201d: women\u2019s perceptions and personal management of vaginal thrush. J Reprod Infant Psychol. 2000;18(4):309\u201319. https:\/\/doi.org\/10.1080\/713683045.","journal-title":"J Reprod Infant Psychol"},{"key":"2165_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2023.108004","volume":"118","author":"T Ford","year":"2024","unstructured":"Ford T, Talbot A, Hayward G, et al. Managing recurrent vulvovaginal thrush from patient and healthcare professional perspectives: a systematic review and thematic synthesis. Patient Educ Couns. 2024;118:108004. https:\/\/doi.org\/10.1016\/j.pec.2023.108004.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"2165_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00938-y","volume":"27","author":"M Erfaninejad","year":"2022","unstructured":"Erfaninejad M, Salahshouri A, Amirrajab N. Barriers and facilitators of adherence to treatment among women with vulvovaginal candidiasis: a qualitative study. Eur J Med Res. 2022;27(1):303. https:\/\/doi.org\/10.1186\/s40001-022-00938-y.","journal-title":"Eur J Med Res"},{"issue":"4","key":"2165_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ctim.2012.01.004","volume":"20","author":"CJ Watson","year":"2012","unstructured":"Watson CJ, Pirotta M, Myers SP. Use of complementary and alternative medicine in recurrent vulvovaginal candidiasis-results of a practitioner survey. Complement Ther Med. 2012;20(4):218\u201321. https:\/\/doi.org\/10.1016\/j.ctim.2012.01.004.","journal-title":"Complement Ther Med"},{"issue":"1","key":"2165_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5694\/j.1326-5377.2003.tb05418.x","volume":"179","author":"MV Pirotta","year":"2003","unstructured":"Pirotta MV, Gunn JM, Chondros P. Not thrush again!\" Women\u2019s experience of post-antibiotic vulvovaginitis. Med J Aust. 2003;179(1):43\u20136. https:\/\/doi.org\/10.5694\/j.1326-5377.2003.tb05418.x.","journal-title":"Med J Aust"},{"key":"2165_CR19","volume-title":"Global traditional medicine strategy 2025\u20132034","author":"World Health Organization","year":"2025","unstructured":"World Health Organization. Global traditional medicine strategy 2025\u20132034. Geneva: World Health Organization; 2025."},{"key":"2165_CR20","unstructured":"Therapeutic Goods Administration. Complementary medicines (Therapeutic Goods Administration). 2023. https:\/\/www.tga.gov.au\/products\/medicines\/non-prescription-medicines\/complementary-medicines. Accessed 25 Nov 2024."},{"issue":"1","key":"2165_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0029-7844(97)00242-1","volume":"90","author":"P Nyirjesy","year":"1997","unstructured":"Nyirjesy P, Weitz MV, Grody MHT, et al. Over-the counter and alternative medicines in the treatment of chronic vaginal symptoms. Obstet Gynecol. 1997;90(1):50\u20133. https:\/\/doi.org\/10.1016\/S0029-7844(97)00242-1.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"2165_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.micinf.2010.04.010","volume":"12","author":"S Ehrstrom","year":"2010","unstructured":"Ehrstrom S, Daroczy K, Rylander E, et al. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes Infect. 2010;12(10):691\u20139. https:\/\/doi.org\/10.1016\/j.micinf.2010.04.010.","journal-title":"Microbes Infect"},{"key":"2165_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10030250","author":"L Witteman","year":"2021","unstructured":"Witteman L, van Wietmarschen HA, van der Werf ET. Complementary medicine and self-care strategies in women with (recurrent) urinary tract and vaginal infections: a cross-sectional study on use and perceived effectiveness in The Netherlands. Antibiotics. 2021. https:\/\/doi.org\/10.3390\/antibiotics10030250.","journal-title":"Antibiotics"},{"key":"2165_CR24","unstructured":"World Health Organization. Traditional, complementary and integrative medicine. 2026. https:\/\/www.who.int\/teams\/integrated-health-services\/traditional-complementary-and-integrative-medicine. Accessed 03 Feb 2026."},{"key":"2165_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jof11110806","author":"D Grando","year":"2025","unstructured":"Grando D, Watson CJ. Perspectives on vaginal ecology and management of recurrent vulvovaginal candidiasis: a narrative review. Journal of Fungi. 2025. https:\/\/doi.org\/10.3390\/jof11110806.","journal-title":"Journal of Fungi"},{"issue":"3","key":"2165_CR26","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6.3.e34","volume":"6","author":"G Eysenbach","year":"2004","unstructured":"Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. https:\/\/doi.org\/10.2196\/jmir.6.3.e34.","journal-title":"J Med Internet Res"},{"key":"2165_CR27","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.2042","author":"G Eysenbach","year":"2012","unstructured":"Eysenbach G. Correction: Improving the quality of web surveys: the checklist for reporting results of internet e-surveys (CHERRIES). J Med Internet Res. 2012. https:\/\/doi.org\/10.2196\/jmir.2042.","journal-title":"J Med Internet Res"},{"key":"2165_CR28","unstructured":"Vulvovaginitis caused by Candida and related species in adult [database on the Internet]. Therapeutic Guidelines (eTG complete): Antibiotic. 2025. Available from: https:\/\/tgldcdp.tg.org.au\/. Accessed: 25 Apr 2025"},{"key":"2165_CR29","unstructured":"Vulvovaginal candidiasis. Australian Medicines Handbook. 2026. https:\/\/amhonline.amh.net.au\/auth. Accessed 3 Feb 2026."},{"issue":"7","key":"2165_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms9071492","volume":"9","author":"E Ottaviano","year":"2021","unstructured":"Ottaviano E, Baron G, Fumagalli L, et al. Candida albicans biofilm inhibition by two Vaccinium macrocarpon (Cranberry) urinary metabolites: 5-(3\u2019,4\u2019-DihydroxyPhenyl)-\u03b3-Valerolactone and 4-Hydroxybenzoic Acid. Microorganisms. 2021;9(7):1\u201313. https:\/\/doi.org\/10.3390\/microorganisms9071492.","journal-title":"Microorganisms"},{"issue":"3","key":"2165_CR31","first-page":"875","volume":"27","author":"V Chopra","year":"2013","unstructured":"Chopra V, Marotta F, Kumari A, et al. Prophylactic strategies in recurrent vulvovaginal candidiasis: a 2-year study testing a phytonutrient vs itraconazole. J Biol Regul Homeost Agents. 2013;27(3):875\u201382.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"2165_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1934578X1701200136","volume":"12","author":"MA Bogavac","year":"2017","unstructured":"Bogavac MA, Karaman MA, Sudi JJ, et al. Antimicrobial potential of Rosmarinus officinalis commercial essential oil in the treatment of vaginal infections in pregnant women. Natural Product Commun. 2017;12(1):127\u201330.","journal-title":"Natural Product Commun"},{"key":"2165_CR33","doi-asserted-by":"publisher","DOI":"10.1088\/1742-6596\/1217\/1\/012136","author":"KY Wenji","year":"2019","unstructured":"Wenji KY, Rukmi I, Suprihadi A. In vitro antifungal activity of methanolic and chloroform mint leaves (Mentha piperita L.) extracts against Candida albicans. J Phys Conf Ser. 2019. https:\/\/doi.org\/10.1088\/1742-6596\/1217\/1\/012136.","journal-title":"J Phys Conf Ser"},{"issue":"4","key":"2165_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.riam.2019.01.003","volume":"36","author":"JT Andrade","year":"2019","unstructured":"Andrade JT, Fantini de Figueiredo G, Cruz LF, et al. Efficacy of curcumin in the treatment of experimental vulvovaginal candidiasis. Rev Iberoam Micol. 2019;36(4):192\u20139. https:\/\/doi.org\/10.1016\/j.riam.2019.01.003.","journal-title":"Rev Iberoam Micol"},{"issue":"4","key":"2165_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3831\/KPI.2021.24.4.191","volume":"24","author":"Z Shiravani","year":"2021","unstructured":"Shiravani Z, Poordast T, Alamdarloo SM, et al. Chamomile extract versus Clotrimazole vaginal cream in treatment of vulvovaginal candidiasis: a randomized double-blind control trial. J Pharmacopuncture. 2021;24(4):191\u20135. https:\/\/doi.org\/10.3831\/KPI.2021.24.4.191.","journal-title":"J Pharmacopuncture"},{"issue":"1","key":"2165_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60178-0","volume":"10","author":"MM Said","year":"2020","unstructured":"Said MM, Watson C, Grando D. Garlic alters the expression of putative virulence factor genes SIR2 and ECE1 in vulvovaginal C. albicans isolates. Sci Rep. 2020;10(1):3615. https:\/\/doi.org\/10.1038\/s41598-020-60178-0.","journal-title":"Sci Rep"},{"key":"2165_CR37","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2147\/IDR.S305503","volume":"14","author":"A Khan","year":"2021","unstructured":"Khan A, Azam M, Allemailem KS, et al. Coadministration of ginger extract and fluconazole shows a synergistic effect in the treatment of drug-resistant vulvovaginal candidiasis. Infect Drug Resist. 2021;14:1585\u201399. https:\/\/doi.org\/10.2147\/IDR.S305503.","journal-title":"Infect Drug Resist"},{"issue":"3-4","key":"2165_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.riam.2020.09.002","volume":"37","author":"DC Moraes","year":"2020","unstructured":"Moraes DC, Reis de Sa LF, Domingos LTS, et al. Synergistic interactions between \u03b2-lapachone and fluconazole in the inhibition of CaCdr2p and CaMdr1p in Candida albicans. Rev Iberoam Micol. 2020;37(3\u20134):104\u20136. https:\/\/doi.org\/10.1016\/j.riam.2020.09.002.","journal-title":"Rev Iberoam Micol"},{"key":"2165_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8040206","author":"M Janeczko","year":"2019","unstructured":"Janeczko M, Kochanowicz E. Silymarin, a popular dietary supplement shows anti-Candida activity. Antibiotics Basel. 2019. https:\/\/doi.org\/10.3390\/antibiotics8040206.","journal-title":"Antibiotics Basel"},{"issue":"3","key":"2165_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12602-016-9218-x","volume":"8","author":"R Davar","year":"2016","unstructured":"Davar R, Nokhostin F, Eftekhar M, et al. Comparing the recurrence of vulvovaginal candidiasis in patients undergoing prophylactic treatment with probiotic and placebo during the 6 months. Probiot Antimicrob Proteins. 2016;8(3):130\u20133. https:\/\/doi.org\/10.1007\/s12602-016-9218-x.","journal-title":"Probiot Antimicrob Proteins"},{"key":"2165_CR41","doi-asserted-by":"publisher","unstructured":"Huang ML, Lin YC, Chen PY, et al. Role of probiotics in recurrent vulvovaginal candidiasis: a randomized controlled trial correlation between pelvic inflammatory disease and tubal infertility: a case-control study. Adv J Biomed Med 2025;13(3):252\u201370. https:\/\/doi.org\/10.18081\/ajbm.2025.3.252.","DOI":"10.18081\/ajbm.2025.3.252"},{"key":"2165_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8070980","author":"T Nunes","year":"2020","unstructured":"Nunes T, Rosa LM, Vega-Chacon Y, et al. Fungistatic action of N-Acetylcysteine on Candida albicans biofilms and its interaction with antifungal agents. Microorganisms. 2020. https:\/\/doi.org\/10.3390\/microorganisms8070980.","journal-title":"Microorganisms"},{"key":"2165_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127200","volume":"265","author":"J Lei","year":"2022","unstructured":"Lei J, Xiao W, Zhang J, et al. Antifungal activity of vitamin D3 against Candida albicans in vitro and in vivo. Microbiol Res. 2022;265:127200. https:\/\/doi.org\/10.1016\/j.micres.2022.127200.","journal-title":"Microbiol Res"},{"issue":"1","key":"2165_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.9735\/0975-5276.1.1.19-24","volume":"1","author":"R Ojha","year":"2009","unstructured":"Ojha R, Manzoor N, Khan LA. Ascorbic acid modulates pathogenecity markers of Candida albicans. Int J Microbiol Res. 2009;1(1):19\u201324. https:\/\/doi.org\/10.9735\/0975-5276.1.1.19-24.","journal-title":"Int J Microbiol Res"},{"issue":"725","key":"2165_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi3363","volume":"15","author":"E Roselletti","year":"2023","unstructured":"Roselletti E, Pericolini E, Nore A, et al. Zinc prevents vaginal candidiasis by inhibiting expression of an inflammatory fungal protein. Sci Transl Med. 2023;15(725):eadi3363. https:\/\/doi.org\/10.1126\/scitranslmed.adi3363.","journal-title":"Sci Transl Med"},{"key":"2165_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9703754","volume":"2018","author":"X Zeng","year":"2018","unstructured":"Zeng X, Zhang Y, Zhang T, et al. Risk factors of vulvovaginal candidiasis among women of reproductive age in Xi\u2019an: a cross-sectional study. BioMed Res Int. 2018;2018:9703754. https:\/\/doi.org\/10.1155\/2018\/9703754.","journal-title":"BioMed Res Int"},{"issue":"5","key":"2165_CR47","first-page":"509","volume":"29","author":"BD Reed","year":"1989","unstructured":"Reed BD, Slattery ML, French TK. The association between dietary intake and reported history of Candida vulvovaginitis. J Fam Pract. 1989;29(5):509\u201315.","journal-title":"J Fam Pract"},{"issue":"10","key":"2165_CR48","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1089\/154099903322643901","volume":"12","author":"BD Reed","year":"2003","unstructured":"Reed BD, Zazove P, Pierson CL, et al. Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis. J Womens Health Larchmt. 2003;12(10):979\u201389. https:\/\/doi.org\/10.1089\/154099903322643901.","journal-title":"J Womens Health Larchmt"},{"key":"2165_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9080445","author":"G Wall","year":"2020","unstructured":"Wall G, Lopez-Ribot JL. Current antimycotics, new prospects, and future approaches to antifungal therapy. Antibiotics. 2020. https:\/\/doi.org\/10.3390\/antibiotics9080445.","journal-title":"Antibiotics"},{"issue":"5","key":"2165_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02406-21","volume":"66","author":"OE Salama","year":"2022","unstructured":"Salama OE, Gerstein AC. Differential response of Candida species morphologies and isolates to Fluconazole and Boric acid. Antimicrob Agents Chemother. 2022;66(5):e0240621. https:\/\/doi.org\/10.1128\/aac.02406-21.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2165_CR51","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/cid\/ciaf673","volume":"82","author":"R Rautemaa-Richardson","year":"2026","unstructured":"Rautemaa-Richardson R, Sobel JD, Stone N, et al. State-of-the-art review: managing vulvovaginal candidiasis. Clin Infect Dis. 2026;82(3):371\u201382. https:\/\/doi.org\/10.1093\/cid\/ciaf673.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2165_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1574-695X.2001.tb01549.x","volume":"30","author":"G Reid","year":"2001","unstructured":"Reid G, Bruce AW, Fraser N, et al. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol. 2001;30(1):49\u201352. https:\/\/doi.org\/10.1111\/j.1574-695X.2001.tb01549.x.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"2165_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0928-8244(02)00465-0","volume":"35","author":"G Reid","year":"2003","unstructured":"Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003;35(2):131\u20134. https:\/\/doi.org\/10.1016\/S0928-8244(02)00465-0.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"9","key":"2165_CR54","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1348-0421.2009.00154.x","volume":"53","author":"RC Martinez","year":"2009","unstructured":"Martinez RC, Seney SL, Summers KL, et al. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation. Microbiol Immunol. 2009;53(9):487\u201395. https:\/\/doi.org\/10.1111\/j.1348-0421.2009.00154.x.","journal-title":"Microbiol Immunol"},{"issue":"4","key":"2165_CR55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/myc.12883","volume":"62","author":"R Russo","year":"2019","unstructured":"Russo R, Superti F, Karadja E, et al. Randomised clinical trial in women with recurrent vulvovaginal candidiasis: efficacy of probiotics and lactoferrin as maintenance treatment. Mycoses. 2019;62(4):328\u201335. https:\/\/doi.org\/10.1111\/myc.12883.","journal-title":"Mycoses"},{"issue":"1","key":"2165_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81931-z","volume":"11","author":"A Pino","year":"2021","unstructured":"Pino A, Rapisarda AMC, Vitale SG, et al. A clinical pilot study on the effect of the probiotic Lacticaseibacillus rhamnosus TOM 22.8 strain in women with vaginal dysbiosis. Sci Rep. 2021;11(1):2592. https:\/\/doi.org\/10.1038\/s41598-021-81931-z.","journal-title":"Sci Rep"},{"issue":"5","key":"2165_CR57","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4103\/ijd.ijd_193_24","volume":"69","author":"AJ Thekho","year":"2024","unstructured":"Thekho AJ, Mendiratta V, Garg T, et al. Role of probiotic in vulvovaginal candidiasis: a randomised controlled non-blinded trial from India. Indian J Dermatol. 2024;69(5):422. https:\/\/doi.org\/10.4103\/ijd.ijd_193_24.","journal-title":"Indian J Dermatol"},{"issue":"3","key":"2165_CR58","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1472-765X.2008.02477.x","volume":"48","author":"RC Martinez","year":"2009","unstructured":"Martinez RC, Franceschini SA, Patta MC, et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol. 2009;48(3):269\u201374. https:\/\/doi.org\/10.1111\/j.1472-765X.2008.02477.x.","journal-title":"Lett Appl Microbiol"},{"key":"2165_CR59","unstructured":"Australian Register of Therapeutic Goods [database on the Internet]. Australian Government Department of Health and Aged Care. n.d. Available from: https:\/\/www.tga.gov.au\/resources\/artg. Accessed: 3 Feb 2026"},{"key":"2165_CR60","doi-asserted-by":"publisher","unstructured":"McCallion RF, Cole AL, Walker JR, et al. Antibiotic substances from New Zealand plants. II. Polygodial, an anti-Candida agent from Pseudowintera colorata. Planta Med. 1982;44(3):134\u20138. https:\/\/doi.org\/10.1055\/s-2007-971422.","DOI":"10.1055\/s-2007-971422"},{"issue":"2","key":"2165_CR61","first-page":"67","volume":"14","author":"C Berry-Kilgour","year":"2002","unstructured":"Berry-Kilgour C. Pseudowintera colorata: a unique New Zealand medicinal herb. Aust J Med Herbalism. 2002;14(2):67\u201370.","journal-title":"Aust J Med Herbalism"},{"key":"2165_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113726","volume":"173","author":"G Baron","year":"2020","unstructured":"Baron G, Altomare A, Regazzoni L, et al. Profiling Vaccinium macrocarpon components and metabolites in human urine and the urine ex-vivo effect on Candida albicans adhesion and biofilm-formation. Biochem Pharmacol. 2020;173:113726. https:\/\/doi.org\/10.1016\/j.bcp.2019.113726.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"2165_CR63","first-page":"543","volume":"25","author":"A Kumari","year":"2011","unstructured":"Kumari A, Bishier MP, Naito Y, et al. Protective effect of an oral natural phytonutrient in recurrent vulvovaginal candidiasis: a 12-month study. J Biol Regul Homeost Agents. 2011;25(4):543\u201351.","journal-title":"J Biol Regul Homeost Agents"},{"key":"2165_CR64","doi-asserted-by":"publisher","unstructured":"Borotova P, Galovicova L, Vukovic NL, et al. Chemical and biological characterization of melaleuca alternifolia essential oil. Plants (Basel). 2022;11(4). https:\/\/doi.org\/10.3390\/plants11040558.","DOI":"10.3390\/plants11040558"},{"issue":"1","key":"2165_CR65","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/CMR.19.1.50-62.2006","volume":"19","author":"CF Carson","year":"2006","unstructured":"Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev. 2006;19(1):50\u201362. https:\/\/doi.org\/10.1128\/CMR.19.1.50-62.2006.","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"2165_CR66","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.resmic.2010.05.002","volume":"161","author":"EH Endo","year":"2010","unstructured":"Endo EH, Cortez DA, Ueda-Nakamura T, et al. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans. Res Microbiol. 2010;161(7):534\u201340. https:\/\/doi.org\/10.1016\/j.resmic.2010.05.002.","journal-title":"Res Microbiol"},{"issue":"3","key":"2165_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/hepo-2020-0016","volume":"66","author":"S Prajapati","year":"2020","unstructured":"Prajapati S, Bhardwaj A, Gupta P. Antioxidant and anti-candida activity of selected medicinal plants of Indian origin. Herba Pol. 2020;66(3):1\u201312. https:\/\/doi.org\/10.2478\/hepo-2020-0016.","journal-title":"Herba Pol"},{"issue":"2","key":"2165_CR68","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2131\/jts.39.353","volume":"39","author":"M Richter","year":"2014","unstructured":"Richter M, Winkel AF, Schummer D, et al. Pau d\u2019arco activates Nrf2-dependent gene expression via the MEK\/ERK-pathway. J Toxicol Sci. 2014;39(2):353\u201361. https:\/\/doi.org\/10.2131\/jts.39.353.","journal-title":"J Toxicol Sci"},{"key":"2165_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25225416","author":"S Caruntu","year":"2020","unstructured":"Caruntu S, Ciceu A, Olah NK, et al. Thuja occidentalis L. (Cupressaceae): ethnobotany, phytochemistry and biological activity. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25225416.","journal-title":"Molecules"},{"key":"2165_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.805612","volume":"8","author":"Y Yong","year":"2021","unstructured":"Yong Y, Fang B, Huang Y, et al. Tea tree oil terpinen-4-ol protects gut barrier integrity by upregulation of tight junction proteins via the ERK1\/2-signaling pathway. Front Nutr. 2021;8:805612. https:\/\/doi.org\/10.3389\/fnut.2021.805612.","journal-title":"Front Nutr"},{"key":"2165_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061140","author":"M Colic","year":"2022","unstructured":"Colic M, Bekic M, Tomic S, et al. Immunomodulatory properties of pomegranate peel extract in a model of human peripheral blood mononuclear cell culture. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14061140.","journal-title":"Pharmaceutics"},{"issue":"1","key":"2165_CR72","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejogrb.2004.02.032","volume":"117","author":"EE Petersen","year":"2004","unstructured":"Petersen EE, Magnani P. Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2004;117(1):70\u20135. https:\/\/doi.org\/10.1016\/j.ejogrb.2004.02.032.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2165_CR73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bbi.2025.03.032","volume":"128","author":"M Sim","year":"2025","unstructured":"Sim M, Hong S, Jung MH, et al. Gut microbiota links vitamin C supplementation to enhanced mental vitality in healthy young adults with suboptimal vitamin C status: a randomized, double-blind, placebo-controlled trial. Brain Behav Immun. 2025;128:179\u201391. https:\/\/doi.org\/10.1016\/j.bbi.2025.03.032.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"2165_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-021-02364-2","volume":"22","author":"CI Le Roy","year":"2022","unstructured":"Le Roy CI, Kurilshikov A, Leeming ER, et al. Yoghurt consumption is associated with changes in the composition of the human gut microbiome and metabolome. BMC Microbiol. 2022;22(1):39. https:\/\/doi.org\/10.1186\/s12866-021-02364-2.","journal-title":"BMC Microbiol"},{"issue":"4","key":"2165_CR75","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1067\/mob.2002.126285","volume":"187","author":"GG Donders","year":"2002","unstructured":"Donders GG, Prenen H, Verbeke G, et al. Impaired tolerance for glucose in women with recurrent vaginal candidiasis. Am J Obstet Gynecol. 2002;187(4):989\u201393. https:\/\/doi.org\/10.1067\/mob.2002.126285.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2165_CR76","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1097\/01.AOG.0000246800.38892.fc","volume":"108","author":"S Ehrstrom","year":"2006","unstructured":"Ehrstrom S, Yu A, Rylander E. Glucose in vaginal secretions before and after oral glucose tolerance testing in women with and without recurrent vulvovaginal candidiasis. Obstet Gynecol. 2006;108(6):1432\u20137. https:\/\/doi.org\/10.1097\/01.AOG.0000246800.38892.fc.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2165_CR77","doi-asserted-by":"publisher","first-page":"195","DOI":"10.32394\/rpzh.2019.0070","volume":"70","author":"M Jeziorek","year":"2019","unstructured":"Jeziorek M, Frej-Madrzak M, Choroszy-Krol I. The influence of diet on gastrointestinal Candida spp. colonization and the susceptibility of Candida spp. to antifungal drugs. Rocz Panstw Zakl Hig. 2019;70(2):195\u2013200. https:\/\/doi.org\/10.32394\/rpzh.2019.0070.","journal-title":"Rocz Panstw Zakl Hig"},{"issue":"2","key":"2165_CR78","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5172\/hesr.2013.22.2.186","volume":"22","author":"HA Baer","year":"2014","unstructured":"Baer HA. The status of women in naturopathy: a view from the United States and Australia. Health Sociol Rev. 2014;22(2):186\u201399. https:\/\/doi.org\/10.5172\/hesr.2013.22.2.186.","journal-title":"Health Sociol Rev"},{"key":"2165_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2020.101220","volume":"40","author":"A Steel","year":"2020","unstructured":"Steel A, Schloss J, Leach M, et al. The naturopathic profession in Australia: a secondary analysis of the Practitioner Research and Collaboration Initiative (PRACI). Complement Ther Clin Pract. 2020;40:101220. https:\/\/doi.org\/10.1016\/j.ctcp.2020.101220.","journal-title":"Complement Ther Clin Pract"},{"issue":"9","key":"2165_CR80","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1111\/sms.14404","volume":"33","author":"JL Nuzzo","year":"2023","unstructured":"Nuzzo JL, Deaner RO. Men and women differ in their interest and willingness to participate in exercise and sports science research. Scand J Med Sci Sports. 2023;33(9):1850\u201365. https:\/\/doi.org\/10.1111\/sms.14404.","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"2165_CR81","doi-asserted-by":"publisher","first-page":"3","DOI":"10.12758\/mda.2021.08","volume":"16","author":"R Becker","year":"2022","unstructured":"Becker R. Gender and survey participation. An event history analysis of the gender effects of survey participation in a probability-based multi-wave panel study with a sequential mixed-mode design. Methoden Daten Analysen. 2022;16(1):3\u201332. https:\/\/doi.org\/10.12758\/mda.2021.08.","journal-title":"Methoden Daten Analysen"},{"issue":"1","key":"2165_CR82","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/her\/16.1.9","volume":"16","author":"A Chapple","year":"2001","unstructured":"Chapple A. Vaginal thrush: perceptions and experiences of women of South Asian descent. Health Educ Res. 2001;16(1):9\u201319. https:\/\/doi.org\/10.1093\/her\/16.1.9.","journal-title":"Health Educ Res"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02165-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02165-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02165-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:58:55Z","timestamp":1789117135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-026-02165-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":82,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2165"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02165-5","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Ethical approval for this study was obtained from The University of Queensland Ethical Review Committee (2022\/HE001188). All participants provided informed consent.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that informed consent was obtained from all study participants.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}